Your browser doesn't support javascript.
loading
The relationship between adjuvant chemotherapy and thiol-disulfide compounds.
Akyol, Pinar; Dede, Didem Sener; Bilgin, Burak; Ulas, Arife; Sendur Mehmet, Ali Nahit; Akinci, Muhammed Bülent; Baser, Salih; Erol, Cihan; Hizal, Mutlu; Yalçin, Bülent.
Afiliación
  • Akyol P; Department of Hematology, Diskapi Yildirim Beyazit Training and Research Hospital, Ankara, Turkey.
  • Dede DS; Departments of Medical Oncology, Yildirim Beyazit University, Ankara, Turkey.
  • Bilgin B; Department of Medical Oncology, Ataturk Chest Disease and Chest Surgery Training and Research Hospital, Ankara, Turkey.
  • Ulas A; Departments of Medical Oncology, Yildirim Beyazit University, Ankara, Turkey.
  • Sendur Mehmet AN; Departments of Medical Oncology, Yildirim Beyazit University, Ankara, Turkey.
  • Akinci MB; Departments of Medical Oncology, Yildirim Beyazit University, Ankara, Turkey.
  • Baser S; Department of Internal Medicine, Yildirim Beyazit University, Ankara, Turkey.
  • Erol C; Departments of Medical Oncology, Yildirim Beyazit University, Ankara, Turkey.
  • Hizal M; Departments of Medical Oncology, Yildirim Beyazit University, Ankara, Turkey.
  • Yalçin B; Departments of Medical Oncology, Yildirim Beyazit University, Ankara, Turkey.
J Cancer Res Ther ; 18(4): 1114-1118, 2022.
Article en En | MEDLINE | ID: mdl-36149169
Asunto(s)
Palabras clave
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Compuestos de Sulfhidrilo / Disulfuros Límite: Female / Humans Idioma: En Revista: J Cancer Res Ther Asunto de la revista: NEOPLASIAS / TERAPEUTICA Año: 2022 Tipo del documento: Article País de afiliación: Turquía
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Compuestos de Sulfhidrilo / Disulfuros Límite: Female / Humans Idioma: En Revista: J Cancer Res Ther Asunto de la revista: NEOPLASIAS / TERAPEUTICA Año: 2022 Tipo del documento: Article País de afiliación: Turquía